Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6455-6474
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6455
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6455
Outcome type | Outpatient medical costs | Hospital costs related to active disease | Total medical costs | ||||||||||||
Regression analysis method | Generalized linear regression analysis | Generalized linear regression analysis | Generalized linear regression analysis | ||||||||||||
Independent variables | Sample size | Coefficient | 95%CI | P value | Sample size | Coefficient | 95%CI | P value | Sample size | Coefficient | 95%CI | P value | |||
Lower | Upper | Lower | Upper | Lower | Upper | ||||||||||
IMT vs CMT | 237 | -1.248 | -1.651 | -0.850 | < 0.001 | 293 | -0.117 | -0.387 | 0.150 | 0.384 | 342 | -0.378 | -0.659 | -0.101 | 0.008b |
BMI | |||||||||||||||
< 18.5 | 293 | 0.753 | 0.240 | 1.225 | 0.003b | 342 | 0.513 | 0.013 | 0.972 | 0.035a | |||||
18.5-23.9 | 293 | 0.214 | -0.276 | 0.657 | 0.367 | 342 | -0.002 | -0.486 | 0.435 | 0.992 | |||||
Lifestyles | |||||||||||||||
Smoker | 237 | 0.563 | -0.529 | 1.824 | 0.263 | ||||||||||
Heavy drinker | 293 | -1.519 | -2.805 | 0.515 | 0.057 | 342 | -1.714 | -2.835 | 0.009 | 0.013a | |||||
Residence area | |||||||||||||||
Urban city | 237 | 0.741 | 0.365 | 1.127 | < 0.001 | ||||||||||
Insurance plan | |||||||||||||||
Urban residents | 237 | -0.562 | -1.038 | -0.030 | 0.028a | ||||||||||
Other plans | 293 | 0.395 | -0.071 | 0.915 | 0.111 | 342 | 0.248 | -0.235 | 0.784 | 0.325 | |||||
Disease site at diagnosis | |||||||||||||||
Terminal ileum | 342 | 0.183 | -0.204 | 0.564 | 0.343 | ||||||||||
Colon | 237 | -0.116 | -0.728 | 0.569 | 0.707 | ||||||||||
Ileocolon | 237 | -0.279 | -0.662 | 0.102 | 0.158 | 293 | -0.252 | -0.513 | 0.010 | 0.060 | 342 | -0.163 | -0.517 | 0.178 | 0.347 |
Ileocolon + upper digestive tract | 342 | 0.600 | -0.073 | 1.397 | 0.106 | ||||||||||
CD-related complications | |||||||||||||||
Intestinal obstruction | 237 | 1.270 | 0.680 | 1.901 | < 0.001 | ||||||||||
Gastric fistula | 342 | -2.351 | -4.061 | 1.308 | 0.049a | ||||||||||
Intestinal abscess | 293 | -1.183 | -2.224 | 0.372 | 0.064 | 342 | -1.180 | -2.174 | 0.261 | 0.050 | |||||
Bowel perforation | 342 | 0.570 | -0.048 | 1.314 | 0.094 | ||||||||||
Perianal abscess | 237 | -0.058 | -0.495 | 0.409 | 0.795 | ||||||||||
Intestinal-cutaneous fistula | 293 | -2.539 | -4.153 | 0.711 | 0.022a | ||||||||||
Extraintestinal manifestations | |||||||||||||||
Psoriasis | 342 | NA | NA | NA | NS | ||||||||||
Mouth ulcers | 237 | -0.089 | -0.933 | 1.004 | 0.852 | 293 | -0.781 | -1.253 | -0.241 | 0.002a | 342 | -0.680 | -1.166 | -0.121 | 0.010a |
History of CD-related surgery | 237 | 0.019 | -0.407 | 0.466 | 0.929 | ||||||||||
Comorbidities | |||||||||||||||
Intestinal ulcer | 237 | -4.250 | -6.471 | 0.449 | 0.004b | ||||||||||
Shingles | 293 | -2.464 | -4.080 | 0.786 | 0.026a | ||||||||||
Joint pain | 342 | -3.952 | -5.675 | -0.291 | 0.001a | ||||||||||
Esophageal disease | 342 | -2.696 | -4.467 | 0.976 | 0.026a | ||||||||||
Diabetes | 342 | -2.147 | -3.910 | 1.523 | 0.076 | ||||||||||
Asthma | 342 | -3.391 | -5.092 | 0.265 | 0.005 |
- Citation: Shi JH, Luo L, Chen XL, Pan YP, Zhang Z, Fang H, Chen Y, Chen WD, Cao Q. Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China. World J Gastroenterol 2020; 26(41): 6455-6474
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6455.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6455